公司概覽
業務類別 Biotechnology
業務概覽 Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
公司地址 53 Frontage Road, Suite 220, Perryville III Building, Hampton, NJ, USA, 08827
電話號碼 +1 908 200-7500
傳真號碼 +1 908 454-1911
公司網頁 https://www.celldex.com
員工數量 198
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Freddy A. Jimenez Senior Vice President and General Counsel -- 21/04/2025
Dr. Margo Heath-Chiozzi, M.D. Senior Vice President, Regulatory Affairs 美元 461.34K 21/04/2025
Ms. Elizabeth Crowley Senior Vice President and Chief Product Development Officer 美元 446.91K 21/04/2025
Mr. Sam Martin Treasurer, Senior Vice President, Secretary, Principal Accounting Officer and Chief Financial Officer 美元 466.47K 25/02/2026
Dr. Diane C. Young, M.D. Senior Vice President and Chief Medical Officer -- 21/04/2025
Mr. Richard M. Wright, PhD Senior Vice President and Chief Commercial Officer -- 21/04/2025
Ms. Sarah Cavanaugh Senior Vice President, Corporate Affairs and Administration -- 21/04/2025
Dr. Ronald A. Pepin, PhD Senior Vice President and Chief Business Officer -- 21/04/2025
Dr. Tibor Keler, PhD Executive Vice President and Chief Scientific Officer 美元 530.73K 21/04/2025
Mr. Anthony S. Marucci Director, President and Chief Executive Officer 美元 751.77K 25/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Keith L. Brownlie Independent Director 25/02/2026
Mr. Herbert J. Conrad Independent Director 28/02/2022
Ms. Cheryl L. Cohen Independent Director 25/02/2026
Dr. Garry A. Neil, M.D. Independent Director 25/02/2026
Mr. Herbert J. Conrad Independent Director 25/02/2026
Mr. Harry H. Penner, Jr Chairman of the Board 25/02/2026
Dr. James J. Marino, J.D. Independent Director 25/02/2026
Mr. Anthony S. Marucci Director, President and Chief Executive Officer 25/02/2026
Dr. Rita I. Jain, M.D. Independent Director 25/02/2026
Ms. Denice M. Torres, J.D.,M.B.A. Independent Director 25/02/2026
 
所屬ETF (更新日期: 07/03/2026 04:18)
代號 名稱 佔比% 持有日期
ITWOProShares Russell 2000 High Income ETF0.004%27/02/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.004%28/02/2026
RFLRInnovator U.S. Small Cp Mgd Flr ETF0.004%25/02/2026
ISCBiShares Morningstar Small-Cap ETF0.003%28/02/2026
DXUVDimensional US Vector Equity ETF0.003%27/02/2026
OMFSInvesco Russell 2000® Dynamic Mltfct ETF0.003%27/02/2026
ACSGAmerican Century Small Cp Gr Insgts ETF0.001%28/02/2026
DFSUDimensional US Sustainability Core 1 ETF0.001%27/02/2026
KBFRInnovator U.S. Small Cap Mgd 10 Bfr ETF0.0004%27/02/2026
PBSMInvesco PureBeta MSCI USA Small Cap ETF0.0004%31/05/2023
HDGProShares Hedge Replication0.0001%27/02/2026
AIEQAI Powered Equity ETF<0.000001%17/05/2023
AIEQAmplify AI Powered Equity ETF<0.000001%27/02/2026
FSSTFidelity Sustainable U.S. Equity ETF<0.000001%31/07/2025
GTPEGoldman Sachs MSCI Wld Priv Eq RtTrkrETF<0.000001%27/02/2026
HKNDHumankind US Stock ETF<0.000001%24/11/2025
IWOiShares Russell 2000 Growth ETF<0.000001%28/02/2026
SMMDiShares Russell 2500 ETF<0.000001%27/02/2026
VTWGVanguard Russell 2000 Growth ETF<0.000001%30/06/2025
  1    2   3  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.